Ligand validation:6FMX

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6FMX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FMX_OLC_A_301	17%	56%	0.22	0.797	0.82	0.89	1	1	0	0	100%	1
6FMX_OLC_A_303	13%	53%	0.23	0.775	0.8	1.01	2	1	1	0	100%	1
6FMX_OLC_A_305	12%	47%	0.205	0.771	1.07	0.97	1	1	4	0	76%	0.76
6FMX_OLC_A_302	8%	55%	0.293	0.764	0.81	0.92	2	1	1	0	100%	1
6FMX_OLC_A_304	2%	55%	0.323	0.618	0.81	0.91	1	1	1	0	100%	1
5JKI_OLC_A_301	12%	56%	0.232	0.806	0.8	0.9	1	1	0	0	76%	0.76
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.